Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
09 2020
Historique:
received: 21 04 2020
accepted: 26 06 2020
pubmed: 18 7 2020
medline: 25 9 2020
entrez: 18 7 2020
Statut: ppublish

Résumé

In late December 2019, a cluster of cases of pneumonia of unknown etiology were reported linked to a market in Wuhan, China

Identifiants

pubmed: 32678356
doi: 10.1038/s41591-020-0997-y
pii: 10.1038/s41591-020-0997-y
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1405-1410

Subventions

Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : 874735
Pays : International
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : 848096
Pays : International
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : 101003589
Pays : International
Organisme : NIAID NIH HHS
ID : HHSN272201400008C
Pays : United States

Investigateurs

G J A P M Oudehuis (GJAPM)
Janke Schinkel (J)
Jan Kluytmans (J)
Marjolein Kluytmans-van den Bergh (M)
Wouter van den Bijllaardt (W)
Robbert G Berntvelsen (RG)
Miranda M L van Rijen (MML)
Peter Schneeberger (P)
Suzan Pas (S)
Bram M Diederen (BM)
Anneke M C Bergmans (AMC)
P A Verspui van der Eijk (PAV)
Jaco J Verweij (JJ)
Anton G N Buiting (AGN)
Roel Streefkerk (R)
A P Aldenkamp (AP)
P de Man (P)
J G M Koelemal (JGM)
D Ong (D)
S Paltansing (S)
N Veassen (N)
Jacqueline Sleven (J)
Leendert Bakker (L)
Heinrich Brockhoff (H)
Ariene Rietveld (A)
Fred Slijkerman Megelink (F)
James Cohen Stuart (J)
Anne de Vries (A)
Wil van der Reijden (W)
A Ros (A)
Esther Lodder (E)
Ellen Verspui-van der Eijk (E)
Inge Huijskens (I)
E M Kraan (EM)
M P M van der Linden (MPM)
S B Debast (SB)
N Al Naiemi (NA)
A C M Kroes (ACM)
Marjolein Damen (M)
Sander Dinant (S)
Sybren Lekkerkerk (S)
Oscar Pontesilli (O)
Pieter Smit (P)
Carla van Tienen (C)
P C R Godschalk (PCR)
Jorien van Pelt (J)
Alewijn Ott (A)
Charlie van der Weijden (C)
Heiman Wertheim (H)
Janette Rahamat-Langendoen (J)
Johan Reimerink (J)
Rogier Bodewes (R)
Erwin Duizer (E)
Bas van der Veer (B)
Chantal Reusken (C)
Suzanne Lutgens (S)
Peter Schneeberger (P)
Mirjam Hermans (M)
P Wever (P)
A Leenders (A)
Henriette Ter Waarbeek (H)
Christian Hoebe (C)

Commentaires et corrections

Type : ErratumIn

Références

Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
pubmed: 7092803 pmcid: 7092803
Gorbalenya, A. E. et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020).
doi: 10.1038/s41564-020-0695-z
Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533–534 (2020).
doi: 10.1016/S1473-3099(20)30120-1
Oude Munnink, B. B. et al. Genomic monitoring to understand the emergence and spread of Usutu virus in the Netherlands, 2016–2018. Sci. Rep. 10, 2798 (2020).
doi: 10.1038/s41598-020-59692-y
Quick, J. et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 530, 228–232 (2016).
doi: 10.1038/nature16996
Faria, N. R. et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 352, 345–349 (2016).
doi: 10.1126/science.aaf5036
Faria, N. R. et al. Genomic and epidemiological monitoring of yellow fever virus transmission potential. Science 361, 894–899 (2018).
doi: 10.1126/science.aat7115
Khoury, M. J. et al. From public health genomics to precision public health: a 20-year journey. Genet. Med. 20, 574–582 (2018).
doi: 10.1038/gim.2017.211
Armstrong, G. L. et al. Pathogen genomics in public health. N. Engl. J. Med. 381, 2569–2580 (2019).
doi: 10.1056/NEJMsr1813907
Polonsky, J. A. et al. Outbreak analytics: a developing data science for informing the response to emerging pathogens. Philos. Trans. R. Soc. B 374, 20180276 (2019).
doi: 10.1098/rstb.2018.0276
Gire, S. K. et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345, 1369–1372 (2014).
pubmed: 4431643 pmcid: 4431643
Modjarrad, K. et al. Developing global norms for sharing data and results during public health emergencies. PLoS Med. 13, e1001935 (2016).
doi: 10.1371/journal.pmed.1001935
Oude Munnink, B. B. et al. Towards high quality real-time whole genome sequencing during outbreaks using Usutu virus as example. Infect. Genet. Evol. 73, 49–54 (2019).
doi: 10.1016/j.meegid.2019.04.015
Oude Munnink, B. B., Nieuwenhuijse, D. F., Sikkema, R. S. & Koopmans, M. Validating whole genome nanopore sequencing, using Usutu virus as an example. J. Vis. Exp. https://doi.org/10.3791/60906 (2020).
Elbe, S. & Buckland-Merrett, G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob. Chall. 1, 33–46 (2017).
doi: 10.1002/gch2.1018
Shu, Y. & McCauley, J. GISAID: Global Initiative on Sharing All Influenza Data—from vision to reality. Eurosurveillance 22, 30494 (2017).
doi: 10.2807/1560-7917.ES.2017.22.13.30494
Amid, C., Pakseresht, N. & Silvester, N. The COMPARE data hubs. Database 2019, baz136 (2019).
doi: 10.1093/database/baz136
Covid-19 (European Bioinformatics Institute; accessed 16 April 2020); https://www.ebi.ac.uk/covid-19
Kraaij – Dirkzwager, M. et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Eurosurveillance 19, 20817 (2014).
doi: 10.2807/1560-7917.ES2014.19.21.20817
Timen, A. Response to imported case of Marburg hemorrhagic fever, the Netherlands. Emerg. Infect. Dis. 15, 1171–1175 (2009).
doi: 10.3201/eid1508.090015
Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25, 2000045 (2020).
pmcid: 6988269
Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protoc. 12, 1261–1276 (2017).
doi: 10.1038/nprot.2017.066
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10–12 (2011).
doi: 10.14806/ej.17.1.200
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
doi: 10.1093/bioinformatics/bty191
Köster, J. & Rahmann, S. Snakemake—a scalable bioinformatics workflow engine. Bioinformatics 28, 2520–2522 (2012).
doi: 10.1093/bioinformatics/bts480
Nguyen, L. T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268–274 (2015).
doi: 10.1093/molbev/msu300
Quang, B. et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 37, 1530–1534 (2020).
Rambaut, A., Lam, T. T., Max Carvalho, L. & Pybus, O. G. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2, vew007 (2016).
doi: 10.1093/ve/vew007
Ayres, D. L. et al. BEAGLE: an application programming interface and high-performance computing library for statistical phylogenetics. Syst. Biol. 61, 170–173 (2012).
doi: 10.1093/sysbio/syr100
Suchard, M. A. et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 4, vey016 (2018).
doi: 10.1093/ve/vey016
Hasegawa, M., Kishino, H. & Yano, T. Dating of the human–ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 22, 160–174 (1985).
doi: 10.1007/BF02101694
Rambaut, A., Drummond, A. J., Xie, D., Baele, G. & Suchard, M. A. Posterior summarization in Bayesian phylogenetics using Tracer 1.7. Syst. Biol. 67, 901–904 (2018).
doi: 10.1093/sysbio/syy032

Auteurs

Bas B Oude Munnink (BB)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

David F Nieuwenhuijse (DF)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Mart Stein (M)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Áine O'Toole (Á)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

Manon Haverkate (M)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Madelief Mollers (M)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Sandra K Kamga (SK)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Claudia Schapendonk (C)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Mark Pronk (M)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Pascal Lexmond (P)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Anne van der Linden (A)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Theo Bestebroer (T)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Irina Chestakova (I)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Ronald J Overmars (RJ)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Stefan van Nieuwkoop (S)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Richard Molenkamp (R)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Annemiek A van der Eijk (AA)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Corine GeurtsvanKessel (C)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Harry Vennema (H)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Adam Meijer (A)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Andrew Rambaut (A)

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

Jaap van Dissel (J)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Reina S Sikkema (RS)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands.

Aura Timen (A)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

Marion Koopmans (M)

ErasmusMC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Rotterdam, the Netherlands. m.koopmans@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH